Prelude Therapeutics Corporate Presentation 2023

Prelude Therapeutics is a precision medicine company developing small molecule therapies for cancer treatment. The company's pipeline includes candidates such as PRT1419, PRT2527, PRT3645, PRT3789, and an oral SMARCA2 candidate in clinical development. This presentation outlines the company's diversified pipeline, commercial opportunities, and R&D capabilities in oncology.